1Svenson KL, Lundqvist G, Wide L, et al. Impaired glucose handling in active rheumatoid arthritis:relationship to peripheral insulin resistance. Metabolism 1988;37:125 - 130.
2Juhan-Vague, I, Thompson SG, Jespersen J, Involvement of the hemostatic system in the insulin resistance syndrome. A study of 1500 patients with angina pectoris. The ECAT Angina Pectoris Study Group. Arterioscler Thromb 1993; 13:1865 - 1873.
3Festa A. D' Agostino R Jr, Howard G, et al. Chronic subclinical inflammation as part of the insulin resistance syndrome:The insulin resistance atherosclerosis study(IRAS). Circulation 2000; 102: 42 - 47.
4Ridker PM, Buring JE. Cook NR, et al. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14719 initially healthy American women. Circulation 2003; 107(3) :391 - 397.
5Venugopal SK. Devaraj S. Yuhanna I, et al. Demonstration that C-reactive protein becrease eNOS expression and bioactivity in human aortic endothelial cells. Circulation 2002;106:1439- 1441.
6Mishima Y, Kuyama A. Tada A, et al. Relationship between serum tumor necrosis factor-alpha and insulin resistance in obese men with type 2 diabetic mellitus. Diabetes Res Clin Prect 2001; 52:119-123.
7Rask-Madsen C, Dominguez H, Ihlemann T, et al. Tumor necrosis factor-alpha inhibit insulin's stimulating effect on glucose uptake and endothelium-dependent vasodilation in human. Circulation 2003; 108:1815 - 1821.
8Kern PA, Di Gregorio GB. Lu T, et al. Adiponectin expression from human adipose tissue: relation to obesity insulin resistance and tumor necrosis factor-α expression. Diabetes 2003; 52:1779 - 1785.
9Segal KR, Landt M, Klein S, et al. Relationship between insulin sensitivity and plasma leptin concentration in lean and obese men.Diabetes 1996;45:988 - 991.
10Kim j, Kim Y-J, Fillmore, J, Chen Y, et al. Prevention of fatinduced insulin resistance by salicylate. J Clin Invest 2001 ;108:437 -446.
4World Health Organization.Definition,diagnonis and classification of diabetes mellitus and its complications,report of a WHO consultation,Part 1:Diagnosis and classification of diabetes mellitus.Geneva:WHO,1999.
5Duclos T W.Function of c-reactive protein[J].Ann Med,2000,32:274-278.
6Volanakis J E.Human c-reactive protein expression,strucures,and function[J].Mol Immunol,2001,38:189-197.
7Freeman D J,Norrie J,Caslake M J,et al.C-reactive protein is an independent predictor of risk for the development of diabetes in the west of scotland coronary prevention study[J].Diabetes,2002,51:1592-1600.
9NAVARRO JF, MORA C, MACA M, et al. Inflammatory parameters are independently associated with urinary albumin in type 2 diabetes mellitus[J]. Am J Kidney Dis, 2003, 42: 53-61.
10SARAHEIMO M, TEPPO AM, FORSBLOM C, et al. Diabetic nephropathy is associated with low-grade inflammation in Type 1 diabetic patients [J]. Diabetologia, 2003, 46: 1402-1407.
